The urogenital system and the menopause

被引:74
|
作者
Calleja-Agius, J. [1 ,2 ]
Brincat, M. P. [3 ]
机构
[1] Univ Malta, Mater Dei Hosp, Dept Obstet & Gynaecol, Msida, Malta
[2] Univ Malta, Dept Anat, Msida, Malta
[3] Mater Dei Hosp, Dept Obstet & Gynaecol, L Imsida, Malta
关键词
UROGENITAL ATROPHY; ESTROGEN; GENITOURINARY SYNDROME OF MENOPAUSE; STRESS URINARY INCONTINENCE; HORMONE REPLACEMENT THERAPY; VAGINAL RING; POSTMENOPAUSAL WOMEN; RECEPTOR; ATROPHY; MANAGEMENT; HEALTH; VULVAR; CREAM; FLORA;
D O I
10.3109/13697137.2015.1078206
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The major cause of urogenital atrophy in menopausal women is estrogen loss. The symptoms are usually progressive in nature and deteriorate with time from the menopausal transition. The most prevalent urogenital symptoms are vaginal dryness, vaginal irritation and itching. The genitourinary syndrome of menopause includes vulvovaginal atrophy and the postmenopausal modifications of the lower urinary tract. Dyspareunia and vaginal bleeding from fragile atrophic skin are common problems. Other urogenital complaints include frequency, nocturia, urgency, stress urinary incontinence and urinary tract infections. Atrophic changes of the vulva, vagina and lower urinary tract can have a large impact on the quality of life of the menopausal woman. However, hormonal and non-hormonal treatments can provide patients with the solution to regain the previous level of function. Therefore, clinicians should sensitively question and examine menopausal women, in order to correctly identify the pattern of changes in urogenital atrophy and manage them appropriately.
引用
收藏
页码:18 / 22
页数:5
相关论文
共 50 条
  • [1] Urogenital effects of the menopause
    Schaffer, J
    Fantl, JA
    BAILLIERES CLINICAL OBSTETRICS AND GYNAECOLOGY, 1996, 10 (03): : 401 - 417
  • [2] Therapy of urogenital menopause syndrome
    Gasimli, Khayal
    Tahmasbi-Rad, Morva
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2023, 21 (02): : 142 - 145
  • [3] Urogenital Menopause- Syndrome more observations
    Wenderlein, J. Matthias
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2015, 75 (05) : 424 - 427
  • [4] Urogenital prolapse and atrophy at menopause: A prevalence study
    Versi, E
    Harvey, MA
    Cardozo, L
    Brincat, M
    Studd, JWW
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2001, 12 (02) : 107 - 110
  • [5] Urogenital Prolapse and Atrophy at Menopause: A Prevalence Study
    E. Versi
    M.-A. Harvey
    L. Cardozo
    M. Brincat
    J. W. W. Studd
    International Urogynecology Journal, 2001, 12 : 107 - 110
  • [7] Menopause: new frontiers in the treatment of urogenital atrophy
    Casarotti, G. A.
    Chiodera, P.
    Tremolada, C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (02) : 567 - 574
  • [8] The role of hormone therapy in urogenital health after menopause
    Nappi, Rossella E.
    Cucinella, Laura
    Martini, Ellis
    Cassani, Chiara
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 35 (06)
  • [9] Vaginal health index score and urogenital syndrome of menopause
    Di Pace, Raffaela
    Portuesi, Rosalba
    GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, 2018, 177 (12) : 741 - 744
  • [10] Associated factors with urogenital score in natural and surgical menopause
    Hassa, H
    Tanir, HM
    Yildirim, A
    Senses, T
    Oge, T
    Mutlu, FS
    MATURITAS, 2005, 52 (01) : 65 - 69